GC 1 compound: Clinical Trials

1 trial of GC 1 compound, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow GC 1 compound: new trials by email Literature Review of GC 1 compound trials Research Report on GC 1 compound

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy
Sobetirome (NV1205) - X-Linked Adrenoleukodystrophy
Phase 1 / Phase 2WithdrawnNeuroVia, Inc.2018-08-012019-03-07

Conditions studied

Adrenoleukodystrophy (1)

Sponsors

NeuroVia, Inc. (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Chile (1)  ·  Colombia (1)  ·  France (1)  ·  Russia (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

John Henderson, MD (1)